Details for Patent: 9,320,714
✉ Email this page to a colleague
Which drugs does patent 9,320,714 protect, and when does it expire?
Patent 9,320,714 protects ACTOPLUS MET and is included in one NDA.
This patent has seven patent family members in six countries.
Summary for Patent: 9,320,714
| Title: | Tablet |
| Abstract: | The present invention can retain the volume of a tablet large without increasing the thickness of the tablet or the like dimension and prevents a plurality of tablets from sticking to each other even if they are subjected to a film-coating or the like treatment, so as to improve the yield. The tablet is a tablet (1) longer in one direction when seen in plan. The tablet (1) has side edges (6) each of which extends in a longitudinal direction and is formed in the shape of a curve projecting outwardly in plan view. The curve has a radius of curvature (R1) set to at least 1.5 times a length (L) of the tablet. This makes a projected area of the tablet (1) in plan view at least 97% with respect to a projected area of a standard elliptical tablet having opposite end portions each of which is formed by a semi-circle having a diameter of a width (W) of the tablet. |
| Inventor(s): | Koike; Masahiko (Osaka, JP), Koyama; Hiroyoshi (Osaka, JP) |
| Assignee: | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka-Shi, JP) |
| Application Number: | 13/082,890 |
|
Patent Claim Types: see list of patent claims | Dosage form; |
Drugs Protected by US Patent 9,320,714
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | ACTOPLUS MET | metformin hydrochloride; pioglitazone hydrochloride | TABLET;ORAL | 021842-001 | Aug 29, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Takeda Pharms Usa | ACTOPLUS MET | metformin hydrochloride; pioglitazone hydrochloride | TABLET;ORAL | 021842-002 | Aug 29, 2005 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,320,714
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2005-102578 | Mar 31, 2005 |
International Family Members for US Patent 9,320,714
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2602184 | ⤷ Try a Trial | |||
| European Patent Office | 1867324 | ⤷ Try a Trial | |||
| Spain | 2593469 | ⤷ Try a Trial | |||
| Japan | 5022893 | ⤷ Try a Trial | |||
| Japan | WO2006106815 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
